These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
272 related items for PubMed ID: 32606113
21. A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids: The first case report in Latin America. José FF, Kerbauy LN, Perini GF, Blumenschein DI, Pasqualin DDC, Malheiros DMAC, Campos Neto GC, de Souza Santos FP, Piovesan R, Hamerschlak N. Medicine (Baltimore); 2017 Mar; 96(13):e6271. PubMed ID: 28353560 [Abstract] [Full Text] [Related]
22. Delayed diagnosis of TAFRO syndrome: A case report. Qiao Y, Zhang X, Xu R, Jia X, Wang Q. Medicine (Baltimore); 2024 Aug 02; 103(31):e39148. PubMed ID: 39093747 [Abstract] [Full Text] [Related]
25. Sequential change in serum VEGF levels in a case of tocilizumab-resistant TAFRO syndrome treated effectively with rituximab. Wakiya R, Kameda T, Takeuchi Y, Ozaki H, Nakashima S, Shimada H, Kadowaki N, Dobashi H. Mod Rheumatol Case Rep; 2021 Jan 02; 5(1):145-151. PubMed ID: 33269653 [Abstract] [Full Text] [Related]
26. Intracranial Hemorrhage in a Patient with TAFRO Syndrome Treated with Cyclosporine A and Rituximab. Akagi Y, Kato T, Yamashita Y, Hosoi H, Murata S, Yamamoto S, Warigaya K, Nakao T, Murata S, Sonoki T, Tamura S. Medicina (Kaunas); 2021 Sep 16; 57(9):. PubMed ID: 34577894 [Abstract] [Full Text] [Related]
27. The Clinical and Histopathological Feature of Renal Manifestation of TAFRO Syndrome. Mizuno H, Sawa N, Watanabe S, Ikuma D, Sekine A, Kawada M, Yamanouchi M, Hasegawa E, Suwabe T, Hoshino J, Takaichi K, Kinowaki K, Fujii T, Ohashi K, Nagata M, Yamaguchi Y, Ubara Y. Kidney Int Rep; 2020 Aug 16; 5(8):1172-1179. PubMed ID: 32775816 [Abstract] [Full Text] [Related]
28. TAFRO syndrome: A disease that known is half cured. Chen T, Feng C, Zhang X, Zhou J. Hematol Oncol; 2023 Aug 16; 41(3):310-322. PubMed ID: 36148768 [Abstract] [Full Text] [Related]
29. TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review. Sakai K, Maeda T, Kuriyama A, Shimada N, Notohara K, Ueda Y. Mod Rheumatol; 2018 May 16; 28(3):564-569. PubMed ID: 26886414 [Abstract] [Full Text] [Related]
37. Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome). Kageyama C, Igawa T, Gion Y, Iwaki N, Tabata T, Tanaka T, Kondo E, Sakai H, Tsuneyama K, Nomoto K, Noguchi H, Yoshino T, Yokota K, Sato Y. Pathol Int; 2019 Oct 01; 69(10):572-579. PubMed ID: 31631463 [Abstract] [Full Text] [Related]
38. A Case of Repeated TAFRO Syndrome-Like Symptoms and Retroperitoneal Hemorrhage in a Patient With Sjögren Syndrome. Ohta T, Oda N, Saito K, Tamiya S, Ueno T. Cureus; 2020 Dec 19; 12(12):e12175. PubMed ID: 33489586 [Abstract] [Full Text] [Related]